Does magnetic resonance imaging-guided biopsy improve prostate cancer detection? A comparison of systematic, cognitive fusion and ultrasound fusion prostate biopsy.

Journal: Prostate international
Published Date: Nov 2, 2017

Abstract

BACKGROUND: The increase in the use of multiparametric magnetic resonance imaging for the detection of prostate cancer has led to the rapid adoption of MRI-guided biopsies (MRGBs). To date, there is limited evidence in the use of MRGB and no direct comparisons between the different types of MRGB. We aimed to assess whether multiparametric MRGBs with MRI-US transperineal fusion biopsy (FB) and cognitive biopsy (CB) improved the management of prostate cancer and to assess if there is any difference in prostate cancer detection with FB compared with CB.

Authors

  • Jonathan Kam
    Nepean Urology Research Group, Nepean Hospital, Penrith New South Wales, Australia.
  • Yuigi Yuminaga
    Nepean Urology Research Group, Nepean Hospital, Penrith New South Wales, Australia.
  • Raymond Kim
    Department of Urology, Gosford District Hospital and Gosford Private Hospital, Gosford, Australia.
  • Kushlan Aluwihare
    PRP Radiology, Gosford, Australia.
  • Finlay Macneil
    Department of Urology, Gosford District Hospital and Gosford Private Hospital, Gosford, Australia.
  • Rupert Ouyang
    Department of Urology, Gosford District Hospital and Gosford Private Hospital, Gosford, Australia.
  • Stephen Ruthven
    Department of Urology, Gosford District Hospital and Gosford Private Hospital, Gosford, Australia.
  • Mark Louie-Johnsun
    Department of Urology, Gosford District Hospital and Gosford Private Hospital, Gosford, Australia.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals